At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 30 enrolled
Drug / intervention
Adenosinedrug
Likely dose
Adenosine 6mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised Controlled Trial of the Standard Versus a Simplified Adenosine Administration Method in the Treatment of Adult Patients With Supra- Ventricular Tachycardia (SVT)
In Brief
A Phase 3 clinical trial evaluating Adenosine for Supra-ventricular Tachycardia. Completed, enrolled 30 participants across 1 site.
Detailed Summary
Study to compare non inferiority of giving adenosine with the simplified method vs the AHA method
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSupra-ventricular Tachycardia
CountriesSouth Africa
Collaborators--
Timeline
Phase 3CompletedFinished
20192020202120222023202420252026
Enrollment StartApr 2018
First PostedMay 2020
Primary CompletionDec 2020
TodayJul 2026
First PostedMay 18, 2020
Enrollment StartApr 1, 2018
Primary CompletionDec 16, 2020
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 6.1 years ago
Interventions
Adenosinedrug
A vial of adenosine with 6mg